Greephire partners with Lyft, updates payment solutions

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Preto_perola)
(Image: Getty/Preto_perola)
Greenphire is partnering with Lyft to enable clinical trial site coordinators to secure rides and reimburse study participants.

Jim Murphy, CEO of Greenphire, said integration with the transportation company will allow study coordinators to order a car, reimburse rides, and provide a stipend all within ClinCard, Greenphire’s participant payment solution.

Several other companies also have partnered with Lyft, including Continuum Clinical​ and ClinOne​. Additionally, Lyft competitor Uber in March 2018 selected Bracket​ as a launch partner for its health care offering.

Site payments

Greenphire also recently announced updates to its clinical trial site payment solution eClinicalGPS.

Murphy told us the software updates enhancements were driven by the growing need for configurable and saleable technology which meets country and study-level requirements.

By enabling clients to choose a delivery model, Murphy said sponsors and contract research organizations (CROs) can determine the level of control that aligns with their global investigator payments process.

“As the clinical trial industry evolves, there is a shift towards a more site-centric model, with a heightened focus on ensuring that investigator sites have a positive trial experience,”​ he said.

Thus, Murphy said sponsors and CROs can no longer rely on a “one-size-fits-all” site payment methodology. “Rather, there is a demand for a more scalable solution that has the flexibility to execute global investigator payments based on unique site needs in order to remove the administrative burden from site staff and give back more time to focus on study-related tasks,”​ he explained.

“Over the next five years, within the clinical trial industry, we foresee a growing desire for flexibility and collaboration to support site-centricity,” ​Murphy said.

Related topics: Clinical Development

Related news

Show more

Follow us


View more